Wells Fargo’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-76,270
| Closed | -$1.37M | – | 6764 |
|
|
2017
Q4 | $1.37M | Sell |
76,270
-950
| -1% | -$11.7K | ﹤0.01% | 3684 |
|
|
2017
Q3 | $911K | Buy |
77,220
+11,649
| +18% | +$131K | ﹤0.01% | 3917 |
|
|
2017
Q2 | $688K | Buy |
65,571
+6,647
| +11% | +$67.8K | ﹤0.01% | 4012 |
|
|
2017
Q1 | $648K | Sell |
58,924
-9,896
| -14% | -$115K | ﹤0.01% | 4072 |
|
|
2016
Q4 | $933K | Sell |
68,820
-17,789
| -21% | -$248K | ﹤0.01% | 3757 |
|
|
2016
Q3 | $1.07M | Buy |
86,609
+4,977
| +6% | +$58.6K | ﹤0.01% | 3448 |
|
|
2016
Q2 | $895K | Sell |
81,632
-334,656
| -80% | -$3.75M | ﹤0.01% | 3559 |
|
|
2016
Q1 | $4.55M | Buy |
416,288
+69,749
| +20% | +$881K | ﹤0.01% | 2349 |
|
|
2015
Q4 | $5.99M | Buy |
346,539
+31,657
| +10% | +$568K | ﹤0.01% | 2200 |
|
|
2015
Q3 | $6.26M | Buy |
314,882
+264,154
| +521% | +$6.06M | ﹤0.01% | 2148 |
|
|
2015
Q2 | $833K | Buy |
50,728
+15,523
| +44% | +$269K | ﹤0.01% | 3742 |
|
|
2015
Q1 | $547K | Sell |
35,205
-3,358
| -9% | -$52.1K | ﹤0.01% | 3890 |
|
|
2014
Q4 | $551K | Buy |
38,563
+18,636
| +94% | +$197K | ﹤0.01% | 3897 |
|
|
2014
Q3 | $129K | Sell |
19,927
-40,930
| -67% | -$272K | ﹤0.01% | 4551 |
|
|
2014
Q2 | $420K | Sell |
60,857
-20,569
| -25% | -$145K | ﹤0.01% | 4007 |
|
|
2014
Q1 | $582K | Hold |
81,426
| – | – | ﹤0.01% | 3788 |
|
|
2013
Q4 | $765K | Buy |
81,426
+10,242
| +14% | +$73.1K | ﹤0.01% | 3578 |
|
|
2013
Q3 | $444K | Sell |
71,184
-296,821
| -81% | -$1.85M | ﹤0.01% | 3816 |
|
|
2013
Q2 | $2.42M | Buy |
+368,005
| New | +$2.92M | ﹤0.01% | 2673 |
|
Other funds holding SCMP
Wells Fargo's SCMP Position: Q1 2018 in Review
Wells Fargo sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 76,270 shares — an estimated $1.37M sold.
Wells Fargo first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $6.26M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Wells Fargo reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Wells Fargo sold 76,270 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.37M.
- Wells Fargo first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Wells Fargo's Sucampo Pharmaceuticals, Inc. position peaked at $6.26M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Wells Fargo's 13F filing for Q1 2018, filed 2 May 2018.